References
- Arteaga C (2003). Targeting HER1/EGFR: a molecular approach to cancer therapy. Semin Oncol, 30, 3-14. https://doi.org/10.1053/S0093-7754(03)00551-7
- Abediankenari S, Jeivad F (2013). Epidermal growth factor receptor gene polymorphisms and gastric cancer in Iran. Asian Pac J Cancer Prev, 14, 3187-90. https://doi.org/10.7314/APJCP.2013.14.5.3187
- Brandacher G , Perathoner A, Ladurner R, et al (2006). Prognostic value of indoleamine 2, 3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res, 12, 1144-51. https://doi.org/10.1158/1078-0432.CCR-05-1966
- Cheang MC, Voduc D, Bajdik C, et al (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res, 14, 1368-76. https://doi.org/10.1158/1078-0432.CCR-07-1658
- Hu Q, Luo Z , Xu T, et al (2014). FOXA1: a promising prognostic marker in breast cancer. Asian Pac J Cancer Prev, 15, 11-6. https://doi.org/10.7314/APJCP.2014.15.1.11
- Ino K, Yoshida N, Kajiyama H, et al (2006). Indoleamine 2, 3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer, 95, 1555-61. https://doi.org/10.1038/sj.bjc.6603477
- Kim H, Choi DH, Park W, et al (2013). Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J, 31, 222-7. https://doi.org/10.3857/roj.2013.31.4.222
- Mansfield AS, Heikkila PS, Vaara AT, et al (2009). Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer, 15, 231.
- Okamoto H, Fujishima F, Nakamura Y, et al (2013). Significance of CD133 expression in esophageal squamous cell carcinoma. World J Surg Oncol, 11, 51. https://doi.org/10.1186/1477-7819-11-51
- Rakha EA, Elsheikh SE, Aleskandarany MA, et al (2009). Triplenegative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res, 15, 2302-10. https://doi.org/10.1158/1078-0432.CCR-08-2132
- Tan DS, Marchio C, Jones RL, et al (2008). Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Tr, 111, 27-44. https://doi.org/10.1007/s10549-007-9756-8
- Tong L, Yang XX, Liu MF, et al (2012). Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients. Asian Pac J Cancer Prev, 13, 5599-603. https://doi.org/10.7314/APJCP.2012.13.11.5599
- Van der Loos CM, Das PK, Houthoff HJ (1987). An immunoenzyme triple-staining method using both polyclonal and monoclonal antibodies from the samespecies. Application of combined direct, indirect, and avidin-biotin complex (ABC) technique. J Histochem Cytochem, 35, 1199-204. https://doi.org/10.1177/35.11.2443555
- Van Noorden S, Stuart MC, Cheung A, et al (1986). Localization of human pituitary hormones by multiple immunoenzyme staining procedures using monoclonal andpolyclonal antibodies. J Histochem Cytochem, 34, 287-92. https://doi.org/10.1177/34.3.2419389
Cited by
- Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition vol.50, pp.6, 2017, https://doi.org/10.3892/ijo.2017.3975
- ) gene expression by real-time PCR among patients with lung cancer pp.00219541, 2019, https://doi.org/10.1002/jcp.28057